Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
13.60
+0.10
+(0.74%)
As of 8:05:02 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-108,985.41
-93,049.09
-67,162.63
-44,599.68
-21,499.59
Investing Cash Flow
-405.55
-89.98
-124.30
-130.03
-42.98
Financing Cash Flow
263,841.50
325,393
8,650.37
143,671.34
101,200.80
End Cash Position
312,809.27
391,231.64
161,837.43
209,353.13
98,628.87
Capital Expenditure
-405.55
-89.98
-124.30
-130.03
-42.98
Issuance of Capital Stock
280,361.78
342,911.32
9,609.87
156,825.70
102,514.88
Repayment of Debt
-187.73
-220.51
-119.53
--
--
Free Cash Flow
-109,390.96
-93,139.08
-67,286.93
-44,729.72
-21,542.57
12/31/2020 - 2/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLNCF Silence Therapeutics plc
1.4700
0.00%
MEB.BE Medincell SA
14.38
-0.96%
NRXS NeurAxis, Inc.
2.1400
-1.83%
IVA.PA Inventiva S.A.
2.6600
+1.53%
XRTX.V XORTX Therapeutics Inc.
1.4900
-3.87%
PBLA Panbela Therapeutics, Inc.
0.3780
+8.00%
IVA Inventiva S.A.
2.7600
-1.78%
GNTA Genenta Science S.p.A.
4.0800
+5.43%
OABI OmniAb, Inc.
3.4100
+1.79%
ABVX ABIVAX Société Anonyme
7.85
+8.88%